Peginterferon Alfa-2a Does Not Alter the Pharmacokinetics of Methadone in Patients with Chronic Hepatitis C Undergoing Methadone Maintenance Therapy*

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2004.09.008 ◽

2005 ◽

Vol 77 (3) ◽

pp. 214-224 ◽

Author(s):

Mark Sulkowski ◽

Teresa Wright ◽

Stephen Rossi ◽

Sanjeev Arora ◽

Matthew Lamb ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Maintenance Therapy ◽

Chronic Hepatitis C ◽

Methadone Maintenance ◽

Methadone Maintenance Therapy ◽

Peginterferon Alfa

Download Full-text

The Effect of Multiple Doses of Peginterferon alfa-2b on the Steady-State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy

The Journal of Clinical Pharmacology ◽

10.1177/0091270007299760 ◽

2007 ◽

Vol 47 (5) ◽

pp. 604-612 ◽

Author(s):

Samir K. Gupta ◽

Edward Sellers ◽

Eugene Somoza ◽

Luis Angles ◽

Karen Kolz ◽

...

Keyword(s):

Chronic Hepatitis ◽

Steady State ◽

Hepatitis C ◽

Maintenance Therapy ◽

Chronic Hepatitis C ◽

Methadone Maintenance ◽

Methadone Maintenance Therapy ◽

Multiple Doses ◽

Peginterferon Alfa

Download Full-text

Pharmacokinetics, pharmacodynamics and antiviral response in patients with chronic hepatitis C infection on methadone maintenance therapy receiving peginterferon (40KD) alfa-2a (pegasys)

Gastroenterology ◽

10.1016/s0016-5085(03)83551-5 ◽

2003 ◽

Vol 124 (4) ◽

pp. A702-A703 ◽

Author(s):

Mark S. Sulkowski ◽

Stephen J. Rossio ◽

Sanjeev Arora ◽

Sreeni Yalamanchili ◽

Matthew W. Lamb

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Maintenance Therapy ◽

Chronic Hepatitis C ◽

Methadone Maintenance ◽

Antiviral Response ◽

Methadone Maintenance Therapy ◽

Hepatitis C Infection

Download Full-text

495 RISK FACTORS FOR FIBROSIS PROGRESSION IN ADDICTED PATIENTS WITH CHRONIC HEPATITIS C ON METHADONE MAINTENANCE THERAPY

Journal of Hepatology ◽

10.1016/s0168-8278(13)60497-3 ◽

2013 ◽

Vol 58 ◽

pp. S203

Author(s):

M. Simonova ◽

D. Takov ◽

I. Vasilevski ◽

N. Tomov ◽

G. Vasilev ◽

...

Keyword(s):

Risk Factors ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Maintenance Therapy ◽

Chronic Hepatitis C ◽

Methadone Maintenance ◽

Methadone Maintenance Therapy ◽

Fibrosis Progression

Download Full-text

Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C

Gastroenterology ◽

10.1053/j.gastro.2011.03.010 ◽

2011 ◽

Vol 140 (7) ◽

pp. 1990-1999 ◽

Author(s):

Jordi Bruix ◽

Thierry Poynard ◽

Massimo Colombo ◽

Eugene Schiff ◽

Kelly Burak ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Maintenance Therapy ◽

Chronic Hepatitis C ◽

Cirrhotic Patients ◽

Peginterferon Alfa

Download Full-text

187 Efficacy and safety of 22 weeks of maintenance therapy with peginterferon alfa-2A (40KD) (PEGASYS™) alone versus peginterferon alfa-2A (40KD) plus ribavirin(COPEGUS™) in naive patients with chronic hepatitis C and genotype 1 who responded to a 24-week course of peginterferon alfa-2A (40KD) plus ribavirin: an open, multicenter, randomized trial

10.1016/s0270-9139(03)80230-6 ◽

2003 ◽

Vol 38 ◽

pp. 244-245 ◽

Author(s):

J BRONOWICKI ◽

D OUZAN ◽

A TZANCK ◽

T ASSELAH ◽

H DESMORAT ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Maintenance Therapy ◽

Randomized Trial ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Multicenter Randomized Trial ◽

Peginterferon Alfa

Download Full-text

Acquired factor IX inhibitor in a patient with cerebral and retroperitoneal haemorrhage after successful treatment of chronic hepatitis C (CHC) with peginterferon-alfa (PEG-IFN-α) plus ribavirin (RBV). a rare complication?

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1254796 ◽

2010 ◽

Vol 48 (05) ◽

Author(s):

A Pálvölgyi ◽

I Nagy ◽

S Modok ◽

T Wittmann

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Successful Treatment ◽

Rare Complication ◽

Factor Ix ◽

Retroperitoneal Haemorrhage ◽

Peginterferon Alfa

Download Full-text

The Role of Weight Loss (WL) as On-Tretament Predictive Factor for SVR in the Treatment of Chronic Hepatitis C (CHC) Patients with Peginterferon alfa–2A (PEG) and Ribavirin (RBV)

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295951 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

T Witthöft ◽

P Buggisch ◽

D Hüppe ◽

R Heyne ◽

C John ◽

...

Keyword(s):

Weight Loss ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Predictive Factor ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020302.793478795 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718013666.793491356 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Dosing Regimen ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718521034.793498216 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Older Patients ◽

Peginterferon Alfa

Download Full-text